BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Denschlag D, Ulrich UA. Uterine Carcinosarcomas - Diagnosis and Management. Oncol Res Treat 2018;41:675-9. [PMID: 30317231 DOI: 10.1159/000494335] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Laguna-Hernández P, Mendoza-Moreno F, Bru-Aparicio M, Alvarado-Hurtado R, Soto-Schütte S, Serrano-Yébenes E, Allaoua-Moussaoui Y, Mañes-Jiménez F, Jiménez-Martín R, Jiménez-Alvarez L, Córdova-Garcia D, Diez-Alonso MM, Gutiérrez-Calvo A. Uterine carcinosarcoma with intestinal involvement: A case report and literature review. Med Int (Lond) 2023;3:15. [PMID: 36925759 DOI: 10.3892/mi.2023.75] [Reference Citation Analysis]
2 Lee JW, Ouh YT, Chang HK, Min KJ, Lee S, Hong JH, Song JY, Lee JK, Lee NW. Trends in Gynecologic Carcinosarcoma Based on Analysis of the Surveillance Epidemiology End Result (SEER) Database. J Clin Med 2023;12. [PMID: 36769835 DOI: 10.3390/jcm12031188] [Reference Citation Analysis]
3 Cantrell LA, Lawson B, Peng K. Uterine carcinosarcoma. Diagnosis and Treatment of Rare Gynecologic Cancers 2023. [DOI: 10.1016/b978-0-323-82938-0.00011-2] [Reference Citation Analysis]
4 Paspulati RM. MRI of malignant uterine tumors. Magnetic Resonance Imaging of the Pelvis 2023. [DOI: 10.1016/b978-0-323-89854-6.00020-x] [Reference Citation Analysis]
5 Chen M, He X, Yang Q, Zhang J, Peng J, Wang D, Tong K, Huang W. Epidemiology and prediction model of patients with carcinosarcoma in the United States. Front Public Health 2022;10:1038211. [PMID: 36518582 DOI: 10.3389/fpubh.2022.1038211] [Reference Citation Analysis]
6 Park S, Park E, Kim HS. Mesonephric-like Carcinosarcoma of the Uterine Corpus: Clinicopathological, Molecular and Prognostic Characteristics in Comparison With Uterine Mesonephric-like Adenocarcinoma and Conventional Endometrial Carcinosarcoma. Cancer Genomics Proteomics 2022;19:747-60. [PMID: 36316041 DOI: 10.21873/cgp.20357] [Reference Citation Analysis]
7 Zhou J, Yang Y, Pan J, Zhou H. A novel hypoxia-related genes signature for prognosis and immunotherapeutic sensitivity in uterine carcinosarcoma patients. Gazz Med Ital - Arch Sci Med 2022;181. [DOI: 10.23736/s0393-3660.22.04799-4] [Reference Citation Analysis]
8 Hao Z, Yang S. The role of postoperative radiotherapy in patients with uterine sarcomas: A PSM-IPTW analysis based on SEER database. Front Surg 2022;9. [DOI: 10.3389/fsurg.2022.985654] [Reference Citation Analysis]
9 Javeed M, Ravuri R, Javeed Z, Taylor S, Akel R. A Rare Case of Intracavitary Cardiac Metastasis of Endometrial Carcinosarcoma. Cureus. [DOI: 10.7759/cureus.25583] [Reference Citation Analysis]
10 Álvarez Sánchez S, Quintero Morillo V, Couso González A, Valenzuela Ruiz P, Díez Corral M, Barreiro García J, Zapico Goñi Á. Cáncer sincrónico de carcinosarcoma uterino y carcinoma seroso tubárico. A propósito de un caso y revisión de la bibliografía. Clínica e Investigación en Ginecología y Obstetricia 2022;49:100738. [DOI: 10.1016/j.gine.2021.100738] [Reference Citation Analysis]
11 Jones TE, Khader S, Jones MW, Lajara SB. Educational Case: Metastatic endometrial stromal sarcoma presenting as bone pain: a diagnostic approach to uterine mesenchymal tumors. Academic Pathology 2022;9:100016. [DOI: 10.1016/j.acpath.2022.100016] [Reference Citation Analysis]
12 Li L, Huang W, Xue K, Feng L, Han Y, Wang R, Gao J. Clinical and imaging features of carcinosarcoma of the uterus and cervix. Insights Imaging 2021;12:142. [PMID: 34674042 DOI: 10.1186/s13244-021-01084-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Salman L, Brudner Y, Silverman BG, Hallak M, Bruchim I. Increased incidence with improved survival of gynecologic carcinosarcoma: A population-based study. Eur J Obstet Gynecol Reprod Biol 2021;266:106-10. [PMID: 34624737 DOI: 10.1016/j.ejogrb.2021.09.025] [Reference Citation Analysis]
14 Liu QF, Feng ZY, Jiang LL, Xu TT, Li SM, Liu KR. Immune Cell Infiltration as Signatures for the Diagnosis and Prognosis of Malignant Gynecological Tumors. Front Cell Dev Biol 2021;9:702451. [PMID: 34222265 DOI: 10.3389/fcell.2021.702451] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Fantappiè G, Malentacchi F, Turrini I, Sorbi F, Castiglione F, Vergoni F, Ammatuna C, Antonuzzo L, Fambrini M, Noci I, Pillozzi S. Detection of PIK3CA E545A mutation in circulating tumor DNA of a patient affected by uterine carcinosarcoma. Anticancer Drugs 2020;31:880-3. [PMID: 32796408 DOI: 10.1097/CAD.0000000000000959] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Beckmann K, Selva-Nayagam S, Olver I, Miller C, Buckley ES, Powell K, Buranyi-Trevarton D, Gowda R, Roder D, Oehler MK. Carcinosarcomas of the Uterus: Prognostic Factors and Impact of Adjuvant Treatment. Cancer Manag Res 2021;13:4633-45. [PMID: 34140809 DOI: 10.2147/CMAR.S309551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Pezzicoli G, Moscaritolo F, Silvestris E, Silvestris F, Cormio G, Porta C, D'Oronzo S. Uterine carcinosarcoma: An overview. Crit Rev Oncol Hematol 2021;163:103369. [PMID: 34051304 DOI: 10.1016/j.critrevonc.2021.103369] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
18 Moukarzel LA, Ferrando L, Da Cruz Paula A, Brown DN, Geyer FC, Pareja F, Piscuoglio S, Papanastasiou AD, Fusco N, Marchiò C, Abu-Rustum NR, Murali R, Brogi E, Wen HY, Norton L, Soslow RA, Vincent-Salomon A, Reis-Filho JS, Weigelt B. The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas. Mol Oncol 2021;15:1024-39. [PMID: 33021035 DOI: 10.1002/1878-0261.12813] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
19 Wang T, Gong J, Li Q, Chu C, Shen W, Peng W, Gu Y, Li W. A combined radiomics and clinical variables model for prediction of malignancy in T2 hyperintense uterine mesenchymal tumors on MRI. Eur Radiol 2021;31:6125-35. [PMID: 33486606 DOI: 10.1007/s00330-020-07678-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
20 Soror NN, Woredekal D, Hemrock L, Gibson G, Bennett R. Uterine Carcinosarcoma in a Young Female: Case Report and Literature Review. Cureus 2021;13:e12642. [PMID: 33585128 DOI: 10.7759/cureus.12642] [Reference Citation Analysis]
21 Shetty MK, Hurtado S. Postmenopausal Bleeding: Role of Imaging in the Diagnosis and Management. Breast & Gynecological Diseases 2021. [DOI: 10.1007/978-3-030-69476-0_12] [Reference Citation Analysis]
22 Vordermark D, Medenwald D, Izaguirre V, Sieker F, Marnitz S. The Role of Postoperative Radiotherapy for Carcinosarcoma of the Uterus. Cancers (Basel) 2020;12:E3573. [PMID: 33265910 DOI: 10.3390/cancers12123573] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Anand SK, Garling RJ, Johns J, Shah M, Chamiraju P. Intradural extramedullary spinal metastases from uterine carcinosarcoma: A case report. Surgical Neurology International 2020;11:354. [DOI: 10.25259/sni_621_2020] [Reference Citation Analysis]
24 Akbari A, Khalili N, Asef-Kabiri L, Negahi A, Raeisi A, Akbari ME. Incidence patterns of gynecological sarcomas in Iran analysis of National Cancer Registry data between 2009 and 2014. J Obstet Gynaecol Res 2020. [PMID: 33029884 DOI: 10.1111/jog.14514] [Reference Citation Analysis]
25 Corrado G, Ciccarone F, Cosentino F, Legge F, Rosati A, Arcieri M, Turco LC, Certelli C, Federico A, Vizza E, Fanfani F, Scambia G, Ferrandina G. Role of minimally invasive surgery versus open approach in patients with early-stage uterine carcinosarcomas: a retrospective multicentric study. J Cancer Res Clin Oncol 2021;147:845-52. [PMID: 32880752 DOI: 10.1007/s00432-020-03372-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
26 Garg S, Dasari P. Clinico-Pathological Profile of Women with Gynaecological Malignancies at a Tertiary Care Institute in South India. Indian J Gynecol Oncolog 2020;18:81. [DOI: 10.1007/s40944-020-00429-0] [Reference Citation Analysis]
27 Mallmann P. Uterine Sarcoma - Difficult to Diagnose, Hard to Treat. Oncol Res Treat 2018;41:674-674. [DOI: 10.1159/000494393] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]